InsiderFlow

Faisal Ghiath Sukhtian

OTLK

Faisal Ghiath Sukhtian serves as director at Outlook Therapeutics, Inc. (OTLK). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

4 trades

$213.9K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$213.9K

Companies Traded

1

OTLK

Active Period

Dec 2021 – Jul 2026

4 total trades

Most Recent

Buy OTLK

Jul 29, 2026 · $100.0K

Faisal Ghiath Sukhtian's Insider Trading at Outlook Therapeutics, Inc. (OTLK)

Buys

4 · $213.9K

Sells

0 · $0.00

Total Shares Bought

265,572

Total Shares Sold

0

OTLK Price Chart
Loading chart...
DateTypeValue
Jul 29, 2026 Buy$100.0K
May 27, 2026 Buy$50.0K
Oct 11, 2022 Buy$38.7K
Dec 2, 2021 Buy$25.2K